The 2nd “Danube Symposium” meeting, together with the 3rd CBmed Biomarker Conference, intended to provide a forum to open-minded experts both from academia and industry in the field of molecular pathology, laboratory medicine, nuclear medicine, clinical pharmacology and beyond who share this vision and like to engage in advancing effective and individualized treatments based on novel and validated diagnostic approaches. It was organised in the astonishing location Park Hyatt Hotel Vienna situated directly in the heart of the city, from the 14th until the 16th of March 2018, with great emphasis by the CBmed GmbH, the Medical University of Vienna and LBI Applied Diagnostics
With more than 100 very international attendees and fabulous speakers out of six countries, the format is growing worldwide. This year’s opening ceremony was moderated by Prof Hacker and Prof Pieber and lead into the interesting key note lecture from Prof Rodney Hicks “Lost in translation? Challenges and Opportunities for Molecular Imaging and Theranostics in the Era of Precision Medicine” who travelled all the way from Melbourne to Vienna.
We are very proud that our Post Doc Raheleh Sheibani was invited to present her poster “Data mining approaches to investigate the biological roles of established biomarkers” with a three minutes oral talk, but also our Postdoctoral Fellow Marie Brandt and our PhD student Thomas Dillinger could proudly present their research projects. Novel perspectives where given within the session dedicated to evidence and ethics under the title “What scientists usually do not consider: Socioeconomic challenges in biomarker development and patient care”.
As part of the organising committee, we want to honestly thank all interested participants, speakers and especially all the organisers and helping hands without whom this event would not have been such a great success.